Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion

Matthew Glen Robertson, Benjamin Bruce Eidenschink, Eriko Iguchi, Stanislav O. Zakharkin, Christopher J. LaRocca, Ezequiel J. Tolosa, Mark J. Truty, Kari Jacobsen, Martin E. Fernandez-Zapico, Julia Davydova

Research output: Contribution to journalArticlepeer-review

Abstract

Sodium iodide symporter (NIS)-expressing oncolytic viruses enable tumor-specific imaging and radiotherapy for infected tumors. We designed a novel NIS-expressing adenoviral vector with deletion of the adenovirus death protein (ADP) gene. ADP deletion improved NIS expression and subsequent imaging capabilities highlighting the role of vector design in effective transgene expression.

Original languageEnglish (US)
Pages (from-to)659-668
Number of pages10
JournalMolecular Therapy - Oncolytics
Volume20
DOIs
StatePublished - Mar 26 2021

Keywords

  • Adenovirus
  • Adenovirus Death Protein
  • Cancer imaging
  • Oncolytic Virus
  • Pancreatic cancer
  • Radiotherapy
  • Sodium-iodide symporter

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion'. Together they form a unique fingerprint.

Cite this